Tirzepatide is a synthetic 39-amino-acid peptide engineered to activate both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor, an approach that has drawn broad interest in metabolic disease research. Because the molecule combines two incretin signaling pathways in one chain, investigators study its effects on glucose handling, insulin secretion and body-weight regulation in cellular and preclinical models. The peptide is presented as a high-purity white lyophilized powder at >=99% HPLC purity in sealed vials, and is reconstituted in buffered solutions for dosing studies. Storage at 2-8 degrees Celsius in the original sealed container is recommended to preserve stability, and the material should be protected from light and moisture. Our sales team confirms specifications, availability and transit time before dispatch, and every parcel is packed with sufficient cushioning for international transport.